The Hemato-Oncology Business Unit provide scientific, medical, regulatory and operational expertise and tailored solutions ensuring successful execution for complex oncology trials.
HEMATO-ONCOLOGY BUSINESS UNIT
TFS dedicated oncology team members understand very well the latest challenges around oncology trials these days- from complex early phase trials including basket trials, precision medicines and immuno-oncology. Utilizing the TFS Oncology team for your trials yield the following benefits:
- Rigorous oversight from study start to end with guaranteed optimal quality execution
- Assigned study team members leverage experience from previous relevant trials ensuring a smooth seamless execution
- Consult with TFS’s true expert Key Opinion Leaders and medical advisors as early as possible within your drug development process which ensures a robust clinical trial design resulting in limited or no feedback from regulatory bodies
- Using quality experienced sites with expedited start up timelines and a timely completion of subject recruitment
- Our approved oncology vendors have ample experience conducting complex analyses successfully
Added Value of the Hemato-Oncology Business Unit
- Global, international and regional experience in oncology
- In-depth therapeutic, scientific & strategic knowledge
- Operational delivery excellence through proactive planning, risk mitigation & standardized processes
- Access to our global KOL and site network
- Partnership minded approach and customer centric focus
- TFS’ most senior personnel, including our Oncology Leadership team commitment and Executive oversight
